0000950170-24-039491.txt : 20240401 0000950170-24-039491.hdr.sgml : 20240401 20240401170602 ACCESSION NUMBER: 0000950170-24-039491 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240401 FILED AS OF DATE: 20240401 DATE AS OF CHANGE: 20240401 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wright Timothy CENTRAL INDEX KEY: 0001383313 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-29089 FILM NUMBER: 24810728 MAIL ADDRESS: STREET 1: C/O ANTIGENICS INC STREET 2: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AGENUS INC CENTRAL INDEX KEY: 0001098972 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 061562417 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-674-4410 MAIL ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: ANTIGENICS INC /DE/ DATE OF NAME CHANGE: 19991115 4 1 ownership.xml 4 X0508 4 2024-04-01 0001098972 AGENUS INC AGEN 0001383313 Wright Timothy C/O AGENUS INC. 3 FORBES ROAD LEXINGTON MA 02421 true false false false false Deferred Stock Units 2024-04-01 4 A false 14134.924 A Common Stock 14134.924 192858.238 D Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. $0.66 per Deferred Stock Unit acquired on April 1, 2024. The price of each Deferred Stock Unit acquired on April 1, 2024 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. /s/Christine Klaskin as Attorney-in-Fact for Timothy R. Wright 2024-04-01